This process leads to hyperglycemia and, at the same time, the insulin feedback pathway causes PI3K/AKT/mTOR pathway activation causing attenuation of the therapeutic response of PI3K inhibitors [234,235]. The gene discussed is PIK3CA; the disease is Hyperglycemia.